Serum CA 19-9 of Pancreatic Solid Mass Patients in Dr. Cipto Mangunkusumo National Central General Hospital
Background: Pancreatic cancer is a lethal disease associated with poor prognosis. CA 19-9 is one of the elevated tumor markers in pancreatic cancer. However, data regarding CA 19-9 serum levels in pancreatic cancer in Indonesia is still scarce. This study aims to evaluate the clinical use of CA 19-9...
Main Authors: | Kaka Renaldi, Adelia Nova Prahasary, Muhammad Hamdan Yuwaafi, Muhammad Maulana |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2020-12-01
|
Series: | The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy |
Subjects: | |
Online Access: | https://www.ina-jghe.com/index.php/jghe/article/view/757 |
Similar Items
-
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
by: Lenka N. C. Boyd, et al.
Published: (2022-01-01) -
The Risk Factors of Pancreatic Cancer Patients in Dr. Cipto Mangunkusumo National Hospital, Jakarta During 2014-2019
by: Kaka Renaldi, et al.
Published: (2020-09-01) -
Survival of Pancreatic Cancer Patients in Dr Cipto Mangunkusumo National Referral Hospital Jakarta from November 2018 To December 2018
by: Kaka Renaldi, et al.
Published: (2020-07-01) -
Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma
by: Wade Christopher, et al.
Published: (2022-12-01) -
Raised CA19-9 in Autoimmune Pancreatitis
by: Sridhar Sundaram, et al.
Published: (2020-05-01)